Mesoblast (ASX:MSB) has announced that the US Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced ...
Humanities and social science funding has been cut from the Marsden Fund, the main fund for 'blue-skies' research in Aotearoa New Zealand. The areas that have been cut include research in subjects ...